Michael Halank

10.1k total citations
153 papers, 5.0k citations indexed

About

Michael Halank is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Michael Halank has authored 153 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Pulmonary and Respiratory Medicine, 69 papers in Cardiology and Cardiovascular Medicine and 15 papers in Surgery. Recurrent topics in Michael Halank's work include Pulmonary Hypertension Research and Treatments (126 papers), Heart Failure Treatment and Management (26 papers) and Cardiovascular Issues in Pregnancy (26 papers). Michael Halank is often cited by papers focused on Pulmonary Hypertension Research and Treatments (126 papers), Heart Failure Treatment and Management (26 papers) and Cardiovascular Issues in Pregnancy (26 papers). Michael Halank collaborates with scholars based in Germany, Switzerland and United States. Michael Halank's co-authors include Marius M. Hoeper, Ralf Ewert, Heinrike Wilkens, Ekkehard Grünig, Christian Opitz, Gert Hoeffken, Hossein Ardeschir Ghofrani, Hans-Juergen Seyfarth, Nicola Ehlken and Roland Wensel and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Michael Halank

143 papers receiving 4.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael Halank 4.3k 3.0k 578 540 513 153 5.0k
Fumio Sakamaki 3.0k 0.7× 1.9k 0.7× 466 0.8× 252 0.5× 477 0.9× 87 4.1k
Jean‐Luc Vachiéry 4.9k 1.1× 3.7k 1.2× 1.2k 2.0× 381 0.7× 601 1.2× 132 6.1k
J. Simon R. Gibbs 4.6k 1.1× 3.4k 1.1× 652 1.1× 325 0.6× 669 1.3× 78 6.0k
Kelly Chin 4.0k 0.9× 2.8k 1.0× 517 0.9× 325 0.6× 479 0.9× 137 4.9k
Paul R. Forfia 4.1k 0.9× 4.1k 1.4× 851 1.5× 174 0.3× 261 0.5× 114 5.9k
Ari Chaouat 7.6k 1.8× 3.2k 1.1× 716 1.2× 577 1.1× 1.1k 2.1× 138 8.6k
Cesar A. Keller 3.2k 0.7× 1.5k 0.5× 993 1.7× 297 0.6× 495 1.0× 79 3.8k
Henning Gall 2.7k 0.6× 2.2k 0.7× 406 0.7× 177 0.3× 313 0.6× 139 3.4k
Nick H. Kim 4.1k 1.0× 3.1k 1.0× 401 0.7× 322 0.6× 1.1k 2.1× 108 4.7k
Isabel Blanco 2.1k 0.5× 1.2k 0.4× 581 1.0× 148 0.3× 284 0.6× 149 3.1k

Countries citing papers authored by Michael Halank

Since Specialization
Citations

This map shows the geographic impact of Michael Halank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Halank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Halank more than expected).

Fields of papers citing papers by Michael Halank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Halank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Halank. The network helps show where Michael Halank may publish in the future.

Co-authorship network of co-authors of Michael Halank

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Halank. A scholar is included among the top collaborators of Michael Halank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Halank. Michael Halank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ghofrani, Hossein Ardeschir, Hanno Leuchte, Hikmet Al‐Hiti, et al.. (2024). ATMOS, a Proof-of-Concept trial of inhaled mosliciguat in untreated PAH or CTEPH. PA5238–PA5238. 2 indexed citations
4.
Halank, Michael, Katarina Zeder, Natascha Sommer, et al.. (2023). Pulmonale Hypertonie assoziiert mit Lungenerkrankungen. Pneumologie. 77(11). 916–925. 1 indexed citations
5.
Grünig, Ekkehard, Nicola Benjamin, Hans‐Jürgen Seyfarth, et al.. (2023). Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?. Pulmonary Circulation. 13(2). e12242–e12242. 4 indexed citations
6.
Ewert, Ralf, Till Ittermann, Michael Halank, et al.. (2022). Prognostic Relevance of Cardiopulmonary Exercise Testing for Patients with Chronic Thromboembolic Pulmonary Hypertension. Journal of Cardiovascular Development and Disease. 9(10). 333–333. 6 indexed citations
7.
Xanthouli, Panagiota, Nicola Benjamin, Ekkehard Grünig, et al.. (2022). Profiles and Treatment Patterns of Patients with Pulmonary Arterial Hypertension on Monotherapy at Experienced Centres. ESC Heart Failure. 9(5). 2873–2885. 9 indexed citations
8.
Leuchte, Hanno, Henrik ten Freyhaus, Henning Gall, et al.. (2018). Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018. International Journal of Cardiology. 272. 20–29. 31 indexed citations
9.
Hoeper, Marius M., Christian Apitz, Ekkehard Grünig, et al.. (2018). Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. International Journal of Cardiology. 272. 37–45. 46 indexed citations
10.
Olschewski, Horst, Jürgen Behr, Hinrich Bremer, et al.. (2018). Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018. International Journal of Cardiology. 272. 63–68. 30 indexed citations
11.
Halank, Michael, et al.. (2017). Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH. Lung. 195(6). 759–768. 24 indexed citations
12.
Ghofrani, Hossein Ardeschir, Gerd Staehler, Ekkehard Grünig, et al.. (2015). Acute Effects of Riociguat in Borderline or Manifest Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. Pulmonary Circulation. 5(2). 296–304. 30 indexed citations
13.
Ewert, Ralf, Heinrike Wilkens, Dirk Skowasch, et al.. (2015). Dyspnoe bei Patienten mit Pulmonaler Hypertonie (PH) – Ergebnisse einer Befragung in deutschen PH-Zentren. Pneumologie. 69(6). 361–365. 1 indexed citations
14.
Seyfarth, Hans‐Jürgen, Stefan Hammerschmidt, Michael Halank, Petra Neuhaus, & Hubert Wirtz. (2013). Everolimus in Patients with Severe Pulmonary Hypertension: A Safety and Efficacy Pilot Trial. Pulmonary Circulation. 3(3). 632–638. 45 indexed citations
15.
Grünig, Ekkehard, Mona Lichtblau, Nicola Ehlken, et al.. (2012). Safety and efficacy of exercise training in various forms of pulmonary hypertension. European Respiratory Journal. 40(1). 84–92. 161 indexed citations
16.
Ghofrani, Hossein Ardeschir, Marius M. Hoeper, Michael Halank, et al.. (2010). Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study. European Respiratory Journal. 36(4). 792–799. 183 indexed citations
17.
Mereles, Derliz, Nicola Ehlken, Sedigheh Ghofrani, et al.. (2006). Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension. Circulation. 114(14). 1482–1489. 466 indexed citations
18.
Halank, Michael, Ralf Ewert, Hans-Juergen Seyfarth, & Gert Hoeffken. (2006). Portopulmonary hypertension. Journal of Gastroenterology. 41(11). 1133–1133. 2 indexed citations
19.
Hoeper, Marius M., Hanno Leuchte, Michael Halank, et al.. (2006). Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension. European Respiratory Journal. 28(4). 691–694. 216 indexed citations
20.
Hoeper, Marius M., Stephen H. Lee, Robert Voswinckel, et al.. (2006). Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers. Journal of the American College of Cardiology. 48(12). 2546–2552. 404 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fumio Sakamaki Breakdown of academic impact, for papers by Jean‐Luc Vachiéry Breakdown of academic impact, for papers by J. Simon R. Gibbs Breakdown of academic impact, for papers by Kelly Chin Breakdown of academic impact, for papers by Paul R. Forfia Breakdown of academic impact, for papers by Ari Chaouat Breakdown of academic impact, for papers by Cesar A. Keller Breakdown of academic impact, for papers by Henning Gall Breakdown of academic impact, for papers by Nick H. Kim Breakdown of academic impact, for papers by Isabel Blanco
Rankless by CCL
2026